antifade mountant with dapi Search Results


90
Corning Life Sciences slowfade gold antifade mountant with dapi s36938
Slowfade Gold Antifade Mountant With Dapi S36938, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antifade+mountant+with+dapi/ppr0424193-177-4-14?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
slowfade gold antifade mountant with dapi s36938 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Verlag GmbH prolong diamond antifade mountant with dapi
Prolong Diamond Antifade Mountant With Dapi, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antifade+mountant+with+dapi/pm28026154-255-9-19?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
prolong diamond antifade mountant with dapi - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Servicebio Inc slowfade gold antifade mountant with dapi
Translocator protein expression is significantly upregulated in mice with colitis, n = 6 in each group. A: The body weight of mice receiving H 2 O or dextran sodium sulfate (DSS) is monitored weekly. Changes in body weight are expressed as a percentage of the original weight at the beginning of the experiments. a P < 0.05, b P < 0.01 vs mice those received H 2 O at the end of the 8 th week; B: Changes in disease activity index score between the two groups during the experiment; C: Gross morphology of the large bowels at the end of the 8 th week after receiving DSS; D: Colon length is measured and recorded. b P < 0.01 vs mice those received H 2 O; E: Histological appearance of colonic sections after hematoxylin and eosin. Original magnification 200 ×; F: Pathological scores of colonic sections are shown in the chart; G: Representative immunofluorescent images of the colonic mucosa for staining with 4'-6-diamidino-2-phenylindole (blue), anti-TSPO (red), and anti-myeloperoxidase (MPO) (green). The white arrows indicate representative TSPO + MPO + cells. Original magnification 400 ×; H: Representative [ 18 F] labeled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-alpha]pyrimidine-3-yl)acetamide (DPA-714) uptake according to micro-positron emission tomography-computed tomography imaging in wild-type (WT) mice with H 2 O and those with DSS treatment. Colon [ 18 F]DPA-714 uptake is higher in the WT mice with DSS treatment than in those with H 2 O treatment. Regions of interest drawn in the colon tissue are showed as white arrows on each image. n : The biologically independent replicates used in the statistical analyses. DSS: Dextran sodium sulfate; TSPO: Translocator protein; MPO: Myeloperoxidase; <t>DAPI:</t> 4'-6-diamidino-2-phenylindole.
Slowfade Gold Antifade Mountant With Dapi, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antifade+mountant+with+dapi/pmc12305146-107-5-11?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
slowfade gold antifade mountant with dapi - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Beijing Solarbio Science antifade mountant containing dapi
Translocator protein expression is significantly upregulated in mice with colitis, n = 6 in each group. A: The body weight of mice receiving H 2 O or dextran sodium sulfate (DSS) is monitored weekly. Changes in body weight are expressed as a percentage of the original weight at the beginning of the experiments. a P < 0.05, b P < 0.01 vs mice those received H 2 O at the end of the 8 th week; B: Changes in disease activity index score between the two groups during the experiment; C: Gross morphology of the large bowels at the end of the 8 th week after receiving DSS; D: Colon length is measured and recorded. b P < 0.01 vs mice those received H 2 O; E: Histological appearance of colonic sections after hematoxylin and eosin. Original magnification 200 ×; F: Pathological scores of colonic sections are shown in the chart; G: Representative immunofluorescent images of the colonic mucosa for staining with 4'-6-diamidino-2-phenylindole (blue), anti-TSPO (red), and anti-myeloperoxidase (MPO) (green). The white arrows indicate representative TSPO + MPO + cells. Original magnification 400 ×; H: Representative [ 18 F] labeled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-alpha]pyrimidine-3-yl)acetamide (DPA-714) uptake according to micro-positron emission tomography-computed tomography imaging in wild-type (WT) mice with H 2 O and those with DSS treatment. Colon [ 18 F]DPA-714 uptake is higher in the WT mice with DSS treatment than in those with H 2 O treatment. Regions of interest drawn in the colon tissue are showed as white arrows on each image. n : The biologically independent replicates used in the statistical analyses. DSS: Dextran sodium sulfate; TSPO: Translocator protein; MPO: Myeloperoxidase; <t>DAPI:</t> 4'-6-diamidino-2-phenylindole.
Antifade Mountant Containing Dapi, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antifade+mountant+with+dapi/pm37979452-88-9-10?v=Beijing+Solarbio+Science
Average 90 stars, based on 1 article reviews
antifade mountant containing dapi - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Translocator protein expression is significantly upregulated in mice with colitis, n = 6 in each group. A: The body weight of mice receiving H 2 O or dextran sodium sulfate (DSS) is monitored weekly. Changes in body weight are expressed as a percentage of the original weight at the beginning of the experiments. a P < 0.05, b P < 0.01 vs mice those received H 2 O at the end of the 8 th week; B: Changes in disease activity index score between the two groups during the experiment; C: Gross morphology of the large bowels at the end of the 8 th week after receiving DSS; D: Colon length is measured and recorded. b P < 0.01 vs mice those received H 2 O; E: Histological appearance of colonic sections after hematoxylin and eosin. Original magnification 200 ×; F: Pathological scores of colonic sections are shown in the chart; G: Representative immunofluorescent images of the colonic mucosa for staining with 4'-6-diamidino-2-phenylindole (blue), anti-TSPO (red), and anti-myeloperoxidase (MPO) (green). The white arrows indicate representative TSPO + MPO + cells. Original magnification 400 ×; H: Representative [ 18 F] labeled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-alpha]pyrimidine-3-yl)acetamide (DPA-714) uptake according to micro-positron emission tomography-computed tomography imaging in wild-type (WT) mice with H 2 O and those with DSS treatment. Colon [ 18 F]DPA-714 uptake is higher in the WT mice with DSS treatment than in those with H 2 O treatment. Regions of interest drawn in the colon tissue are showed as white arrows on each image. n : The biologically independent replicates used in the statistical analyses. DSS: Dextran sodium sulfate; TSPO: Translocator protein; MPO: Myeloperoxidase; DAPI: 4'-6-diamidino-2-phenylindole.

Journal: World Journal of Gastroenterology

Article Title: Translocator protein facilitates neutrophil-mediated mucosal inflammation in inflammatory bowel diseases

doi: 10.3748/wjg.v31.i27.109239

Figure Lengend Snippet: Translocator protein expression is significantly upregulated in mice with colitis, n = 6 in each group. A: The body weight of mice receiving H 2 O or dextran sodium sulfate (DSS) is monitored weekly. Changes in body weight are expressed as a percentage of the original weight at the beginning of the experiments. a P < 0.05, b P < 0.01 vs mice those received H 2 O at the end of the 8 th week; B: Changes in disease activity index score between the two groups during the experiment; C: Gross morphology of the large bowels at the end of the 8 th week after receiving DSS; D: Colon length is measured and recorded. b P < 0.01 vs mice those received H 2 O; E: Histological appearance of colonic sections after hematoxylin and eosin. Original magnification 200 ×; F: Pathological scores of colonic sections are shown in the chart; G: Representative immunofluorescent images of the colonic mucosa for staining with 4'-6-diamidino-2-phenylindole (blue), anti-TSPO (red), and anti-myeloperoxidase (MPO) (green). The white arrows indicate representative TSPO + MPO + cells. Original magnification 400 ×; H: Representative [ 18 F] labeled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-alpha]pyrimidine-3-yl)acetamide (DPA-714) uptake according to micro-positron emission tomography-computed tomography imaging in wild-type (WT) mice with H 2 O and those with DSS treatment. Colon [ 18 F]DPA-714 uptake is higher in the WT mice with DSS treatment than in those with H 2 O treatment. Regions of interest drawn in the colon tissue are showed as white arrows on each image. n : The biologically independent replicates used in the statistical analyses. DSS: Dextran sodium sulfate; TSPO: Translocator protein; MPO: Myeloperoxidase; DAPI: 4'-6-diamidino-2-phenylindole.

Article Snippet: Coverslips were mounted using the Slowfade Gold antifade mountant with DAPI (Servicebio, 1:1000) for DNA counterstaining.

Techniques: Expressing, Activity Assay, Staining, Labeling, Micro-PET, Computed Tomography, Imaging

Dextran sodium sulfate-induced colitis leads to changes in translocator protein expression and several types of neural cells in the brain. A and B: Representative immunofluorescent images for staining with 4'-6-diamidino-2-phenylindole (DAPI) (blue), anti-translocator protein (TSPO) (red), and anti-glial fibrillary acidic protein (green) in the hippocampus and cerebral cortex of representative sections from the brain of two groups. Original magnification: (1) Up 200 ×; and (2) Down 400 ×; C and D: Representative immunofluorescent images for staining with DAPI (blue), anti-TSPO (red), and anti-IBA1 (green) in the hippocampus and cerebral cortex of representative sections from the brain of two groups. Original magnification: (1) Up 200 ×; and (2) Down 400 ×. n : The biologically independent replicates used in the statistical analyses. DAPI: 4'-6-diamidino-2-phenylindole; DSS: Dextran sodium sulfate; GFAP: Glial fibrillary acidic protein; TSPO: Translocator protein.

Journal: World Journal of Gastroenterology

Article Title: Translocator protein facilitates neutrophil-mediated mucosal inflammation in inflammatory bowel diseases

doi: 10.3748/wjg.v31.i27.109239

Figure Lengend Snippet: Dextran sodium sulfate-induced colitis leads to changes in translocator protein expression and several types of neural cells in the brain. A and B: Representative immunofluorescent images for staining with 4'-6-diamidino-2-phenylindole (DAPI) (blue), anti-translocator protein (TSPO) (red), and anti-glial fibrillary acidic protein (green) in the hippocampus and cerebral cortex of representative sections from the brain of two groups. Original magnification: (1) Up 200 ×; and (2) Down 400 ×; C and D: Representative immunofluorescent images for staining with DAPI (blue), anti-TSPO (red), and anti-IBA1 (green) in the hippocampus and cerebral cortex of representative sections from the brain of two groups. Original magnification: (1) Up 200 ×; and (2) Down 400 ×. n : The biologically independent replicates used in the statistical analyses. DAPI: 4'-6-diamidino-2-phenylindole; DSS: Dextran sodium sulfate; GFAP: Glial fibrillary acidic protein; TSPO: Translocator protein.

Article Snippet: Coverslips were mounted using the Slowfade Gold antifade mountant with DAPI (Servicebio, 1:1000) for DNA counterstaining.

Techniques: Expressing, Staining